ZIKANI THERAPEUTICS, INC.

Profile

Company Names

ZIKANI THERAPEUTICS, INC.
MACROLIDE PHARMACEUTICALS, INC.

Addresses

480 ARSENAL ST., STE. 130, WATERTOWN, MA 02472

480 ARSENAL STREET, SUITE 130, WATERTOWN, MA 02472

3 NEWTON EXECUTIVE PARK, SUITE 101, NEWTON, MA 02462

Phone Numbers

617-229-6503
617-645-4982
617-453-9091

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$31,676,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-04-01 
$7,500,000.00 
$7,500,000.00 
$0.00 
Equity 
2
2018-03-01 
$12,000,000.00 
$20,000,000.00 
$8,000,000.00 
Debt 
1
2015-02-10 
$12,176,000.00 
$27,800,000.00 
$15,624,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUMIT 
 
AGGARWAL 
EXECUTIVE OFFICER, DIRECTOR
PROGENITY, INC.   |  ZIKANI THERAPEUTICS, INC.
FEREYDOUN 
 
FIROUZ 
DIRECTOR
MACROLIDE PHARMACEUTICALS, INC.
MARKUS 
 
GOEBEL 
DIRECTOR
TRELLIS BIOSCIENCE INC   |  LIGOCYTE PHARMACEUTICALS INC   |  SORBENT THERAPEUTICS INC   |  EFFECTOR THERAPEUTICS, INC.   |  RA PHARMACEUTICALS, INC.   |  MERGANSER BIOTECH, INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  E-SCAPE BIO, INC.
VIKAS 
 
GOYAL 
DIRECTOR
CALCIMEDICA INC   |  MACROLIDE PHARMACEUTICALS, INC.   |  MORPHIC HOLDING, LLC   |  SPERO THERAPEUTICS, LLC   |  PANDION THERAPEUTICS, INC.   |  PANDION THERAPEUTICS HOLDCO LLC
ANJA 
 
HARMEIER 
DIRECTOR
MACROLIDE PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.
ANDREW 
 
LITTLEHALE 
EXECUTIVE OFFICER
FORMA THERAPEUTICS HOLDINGS LLC   |  MACROLIDE PHARMACEUTICALS, INC.
EDWARD 
 
MASCIOLI 
EXECUTIVE OFFICER
AFFINIUM PHARMACEUTICALS LTD   |  MACROLIDE PHARMACEUTICALS, INC.
LAWRENCE 
 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
SEQUELLA INC   |  TETRAPHASE PHARMACEUTICALS INC   |  DANFORTH PEWTERERS LTD   |  STONEMOR PARTNERS LP   |  STONEMOR OPERATING LLC   |  STONEMOR INDIANA LLC   |  PANGENX, INC.   |  HOLGANIX, LLC   |  CUSTOMINK, LLC   |  SEQUELLA INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  APNIMED, INC.
ANDREW 
 
MYERS 
DIRECTOR
KELP CAPITAL INVESTORS, LLC (MAVRIK SERIES)   |  ONESUN, INC.   |  RIPPLE RECRUITING INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  RIPPLEMATCH INC.   |  SATOSHI ENERGY CORP   |  CROSSLAYER CAPITAL FUND I, L.P.   |  CROSSLAYER CAPITAL FUND II, L.P.   |  CROSSLAYER CAPITAL FUND II FEEDER, L.P.
ANDREW 
G. 
MYERS 
DIRECTOR
MACROLIDE PHARMACEUTICALS, INC.
RAJ 
 
PAREKH 
DIRECTOR
AVILA THERAPEUTICS INC   |  PRANALYTICA INC   |  ARTAX BIOPHARMA, INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  ARRAKIS THERAPEUTICS, INC.
RAJ 
B. 
PAREKH, PH.D. 
DIRECTOR
ZIKANI THERAPEUTICS, INC.
MONIQUE 
 
SCIERSING 
DIRECTOR
MACROLIDE PHARMACEUTICALS, INC.
HENRY 
 
SKINNER 
DIRECTOR
AVILA THERAPEUTICS INC   |  THESAN PHARMACEUTICALS, INC.   |  AEGLEA BIOTHERAPEUTICS HOLDINGS, LLC   |  GALERA THERAPEUTICS, INC.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  PROTEOSTASIS THERAPEUTICS, INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  CAVION, INC.   |  NEUROVIA, INC.   |  GENOMEDX INC.   |  CURASEN THERAPEUTICS, INC.   |  DECIPHER BIOSCIENCES, INC.
MARY 
 
SZELA 
DIRECTOR
SUNEVA MEDICAL INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  KURA ONCOLOGY, INC.   |  TRISALUS LIFE SCIENCES, INC.
CHRISTOPHER 
 
VIEHBACHER 
DIRECTOR
MACROLIDE PHARMACEUTICALS, INC.   |  VEDANTA BIOSCIENCES, INC.
CHRISTOPHER 
A. 
VIEHBACHER 
DIRECTOR
ZIKANI THERAPEUTICS, INC.
JOSEPH 
 
ZAKRZEWSKI 
DIRECTOR
PROMEDIOR INC   |  ZELOS THERAPEUTICS INC   |  XCELLEREX, INC.   |  AZELON PHARMACEUTICALS, INC.   |  THRASOS INNOVATION INC.   |  HAPTEN SCIENCES, INC.   |  SITEONE THERAPEUTICS, INC.   |  MACROLIDE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-04-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-01 
2018-03-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-03-01 
2016-04-29
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-10 
2015-02-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#